The complications of DM are not only common but devastating, and include lower extremity amputations (LEAs), blindness and renal failure, with DM being the most common cause for non-traumarelated LEAs. There is a wide range in the proportion of LEAs due to DM, with studies showing that up to 90% of LEAs worldwide are associated with DM and up to 70% of patients who undergo an LEA die within 5 years of the operation. [6, 9, 10] There are some African data on diabetes-related LEAs, primarily from small tertiary hospital studies. In each, diabetic foot complications were the major indication for non-traumatic LEAs. [11] [12] [13] There are, however, few published data available for SA, and this study attempts to address this deficit, providing a baseline from which further monitoring and planning can be done.
The aim of this study was to examine the contribution of DM to the burden of LEAs in four public sector hospitals in Cape Town, SA, during 2009 and 2010. The objectives were to determine the demographic characteristics of patients undergoing LEAs, the proportion of these amputations due to DM, the comorbidities, risk factors, causes and complications associated with these LEAs, and the number and sites of these LEAs.
Methods
The study was a retrospective analysis of all LEAs performed in four Cape Town public sector hospitals: Groote Schuur Hospital, a tertiary level hospital, and its associated secondary level hospitals, Somerset, Victoria and G F Jooste Hospitals, from 1 January 2009 to 31 December 2010. These are the public sector hospitals that perform LEAs in the western portion of the Cape Town metropole. Cape Town is situated in the Western Cape Province of SA and has a heterogeneous population of approximately 3.5 million people. Like the rest of SA, disease management is split between the public and private sectors, with 80% of the population being dependent on the public sector. [14, 15] All cases of LEAs, defined as the surgical removal of part of the lower limb by transection of the leg, foot or digit, necessarily including the removal of bone, [16] were identified from the theatre registers of these four hospitals for 2009 and 2010. All cases including the terms above-knee amputation (AKA), through-knee amputation (TKA), below-knee amputation (BKA), supramalleolar amputation (SMA), forefoot/transmetatarsal amputation (TMA) and digit amputation (DA) were included as an LEA in this study.
The identified patients' records were requested from the corresponding hospitals' records departments, and information was extracted using a structured data capture form. The data collected included number and length of admissions, demographic 
Results
As seen in Fig. 1 The mean age (standard deviation (SD)) of all included patients was 62.2 (12.74) years. There was no significant difference in the mean age of men and women within and between the DM and non-DM groups. There were similar proportions of men and women in the DM group (50.1% and 49.9%, respectively), but twice as many men as women in the non-DM group (66.8% v. 33.2%, p<0.001). (The patient records no longer include a population classification code, so this information is not reported.) Type 2 DM accounted for the majority of the patients in the DM group (n=551, 92.9%); 7 patients (1.2%) had type 1 DM, while the type of diabetes was unknown in 35 (5.9%). Regarding therapy, 299 (50.4%) were on oral therapy, 104 (17.5%) were on insulin, 128 (21.6%) were on a combination of oral and insulin therapy, 3 (0.5%) were on no therapy, 7 (1.2%) were on diet alone and therapy in 52 (8.8%) was unknown. Table 1 summarises the comorbidities, risk factors, causes and complications asso ciated with an LEA in the DM and non-DM groups.
Comorbidities. Hypertension, ischaemic heart disease (IHD) and renal impairment were significantly more common in the DM group than in the non-DM group (p<0.001).
Conversely, associated alcohol use, asthma/ chronic obstructive pulmonary disease (COPD) and HIV infection, were more common in the non-DM than the DM group (p<0.001), but associated cerebral vascular accidents (CVAs)/transient ischaemic attacks (TIAs) and congestive cardiac failure frequencies did not differ in the DM and non-DM groups.
Associated risk factors. Smoking was the only associated risk factor that was significantly different between the two groups (43.5% in the DM group and in 69.7% in the non-DM group; p<0.001).
Causes of the LEAs. Infection was the major cause of LEAs in both groups, albeit significantly higher in the DM group (p<0.001). Ischaemia accounted for a significantly greater proportion of LEAs in the non-DM group (p<0.001), whereas an ulcer was responsible for a significantly greater proportion of LEAs in the DM group (p=0.001). Less common causes, including burns (p<0.05), were more common in the DM group, while malignancy (p<0.01), limb deformity (p<0.05), neurological disorder (p<0.01) and HIV vasculopathy (p<0.01) were more common in the non-DM group.
Complications associated with the LEAs. There were significant differences for the main complications between the two groups, with a further LEA, sepsis and debridement being more common in the DM group than the non-DM group (p<0.05). There was no significant difference for the other main complications of in-hospital death, blood transfusion, and intensive care unit (ICU) admission, or regarding other complications of deep-vein thrombosis (DVT), upper gastrointestinal tract (GIT) bleed and pneumonia between the DM and non-DM groups, although these numbers were very small.
The median duration of hospital admission was 9 days, with an interquartile range of 7 days for both groups, and a range of 1 -45 The DM group had a greater proportion of current multiple LEAs than the non-DM group (42% v. 23%, p<0.001), while 20.4% in the DM group and 17.2% in the non-DM group had an LEA prior to the commencement of the study.
As seen in Fig. 2 , the proportions of multi ple toectomies and TMAs did not differ significantly between the two groups. However, the proportions of single toectomies (p=0.002), SMAs (p<0.0001), and BKAs (p<0.0001), were higher in the DM patients, while TKAs (p<0.0001) and AKAs (p<0.0001) were higher in the non-DM group.
Discussion
DM accounted for the vast majority of nontraumatic LEAs performed in 2009 and 2010 in four public sector hospitals in Cape Town. On average six (number rounded up from 5.7) DM patients had nine (number rounded up from 8.9) LEAs per week over the 2-year period.
These data highlight the considerable burden that diabetes-related LEAs impose on local health services. This is in keeping with numerous studies conducted elsewhere that have stated that LEAs represent a considerable cost for such services, not only for the admission and amputation, but also for the additional components of rehabilitation, home care and social services. [6, 9, 17, 18] The human cost is also considerable for the patients, their families and society. The best way to decrease these costs is to decrease the number of foot complications, including LEAs. This study found that the associated co morbidities of hypertension, IHD and renal impairment were more common in the DM patients. This is similar to other studies and is thought to be due in part to the increasing westernisation of lifestyles. [3, 19, 20] The associated renal impairment probably reflects complications of DM due to poor glycaemic control.
Smoking was the only associated risk factor found to be different, being more prevalent in non-DM patients. This was also reflected in the fact that associated asthma/COPD was more prevalent in the non-DM group. Yet a large proportion of DM patients (43%) smoked, which is of concern, as smoking is known to increase the risk of LEAs in people with DM. [19] Associated peripheral vascular disease (PVD) was similar between the DM and non-DM groups, with about 25% of patients noted to have PVD as a risk factor, which is similar to a previous study.
[ 21] This study found only a small number of patients with associated peripheral neuropathy in the DM group, yet peripheral neuropathy is known to be a substantial cause of foot complications including LEAs. [8, 22] The number of patients with associated peripheral neuropathy is probably artificially low, reflecting under-reporting in the patient records.
A preceding ulcer and infection were the more common causes for LEAs in the DM patients, which is in keeping with what previous studies have shown. [3, 9, 17, 19, 23] Ischaemia was the most common cause for LEAs in the non-DM patients, perhaps reflecting the higher rate of smoking in this group. Burns causing LEAs were more common in the DM group and can probably be attributed to associated peripheral neuropathy. Under-reporting of peripheral neuropathy probably reflects failure on the part of healthcare workers to screen for this complication. They are therefore not educating patients on the danger of infections, burns, etc.
Post-LEA sepsis and debridements were found to be more common in the DM patients. This was expected, as sepsis was often the cause for the LEA in this group. Nearly 20% of LEAs in DM patients were SMAs. This indicates that sepsis was a major cause, as this operation is usually a sepsis control procedure, the definitive procedure being a BKA or AKA. It is also notable that the percentage of AKAs in the non-DM group was double that in the DM group. This may be because DM patients have more LEAs due to an ulcer or infection, requiring a more distal amputation, whereas non-DM patients have more LEAs due to ischaemia, requiring a more proximal amputation. The greater proportion of current, multiple LEAs in the DM group compared with the non-DM group reflects the fact that 'creeping' LEAs, i.e. multiple LEAs that start distally and progress proximally, are more prevalent in the DM group.
The strengths of this study are the large numbers of patients identified with a good recovery rate, as well as similar methodology employed as in other global studies. [24] However, it has a number of limitations. Its retrospective nature allowed only for information recorded in the patient folders to be evaluated. Accurate data for comorbidities, risk factors, causes and complications associated with a LEA would require a prospective study. The records often revealed limited information on other factors such as the level of glycaemic control, duration of DM and obesity. The study was undertaken only in the public sector, thus underestimating the true burden of diabetes-related LEAs. Because of the lack of accurate data on DM incidence and population size in the study area, it is difficult to extrapolate the number of LEAs identified in this study to the prevalence of diabetes-related LEAs.
It is well known that the majority of foot complications, including LEAs, are preventable with adequate patient education, screening, treatment and follow-up. [3, 16, 23, 25, 26] In this regard we have previously demonstrated that a third of patients attending primary care clinics in Cape Town had 'at-risk feet' although this had often been unrecorded in the clinic notes. [27] A number of reasons may account for suboptimal foot care: high patient numbers and decreased consultation times leading to infrequent foot examinations, limited opportunities for patient education and therefore non-adherence, as well as inadequate overall treatment at a primary healthcare level. [6, 19, 28] While preventive diabetes foot care is not the sole preserve of the doctor or a podiatrist, it is important to note that there is a lack of podiatrists to adequately prevent and treat these complications. Nurses, health promoters and community health workers can all contribute to a diabetes foot programme, but would need to receive appropriate training to enable patients to be active participants in their own care, to screen for at-risk feet and to refer appropriately for further management.
Conclusions
This study highlights the enormous burden of LEAs in the public sector. There is clearly an urgent need to develop and implement foot care programmes to reduce the personal, societal and disease management costs associated with LEAs. This study provides a baseline against which the effectiveness of interventions can be measured in the future.
